Assesment of erythroferrone levels in neonates with anaemia of prematurity
Keywords:
anaemia, erythroferrone, hepcidin, prematurityAbstract
Background: The anemia of prematurity is caused by untimely birth occurring before placental iron transport and fetal erythropoiesis are complete. Objective: To determine the serum levels of erythroferrone and their relation to the anaemia of prematurity. Patients and methods: This study was case control study carried out in the the Pediatric Department, Faculty of Medicine, Menoufia University. This study included two groups; the first group included newborns of both sexes with anemia of prematurity admitted to the NICU during the study period, the 2nd group included group of healthy newborns. all participants were subjected to history taking, general examination, Local examination, Abdominal examination and Laboratory investigations including complete blood count (CBC), and blood film, C reactive protein (CRP), Blood culture when needed, Kidney functions tests: including serum creatinine and urea, Liver function tests: including serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT), Hepcidin level and Erythroferrone. Results: There was no statistically significant difference in liver, renal functions, CRP. Hepcidin showed significant decrease in diseased group when compared to the control group. Free erythroferrone levels showed significant increase in diseased group when compared to the control group.
Downloads
References
Aher, S., K. Malwatkar, and S. Kadam. Neonatal anemia. in Seminars in fetal and neonatal medicine. 2008. Elsevier.
Andersen, C.C., A.K. Keir, H.M. Kirpalani, and M.J. Stark, Anaemia in the Premature Infant and Red Blood Cell Transfusion: New Approaches to an Age-Old Problem. Current Treatment Options in Pediatrics, 2015. 1(3): p. 191-201.
Carroll, P.D. and J.A. Widness. Nonpharmacological, blood conservation techniques for preventing neonatal anemia—effective and promising strategies for reducing transfusion. in Seminars in perinatology. 2012. Elsevier.
Cibulskis, C.C., A. Maheshwari, R. Rao, and A.M. Mathur, Anemia of prematurity: how low is too low? Journal of Perinatology, 2021. 41(6): p. 1244-1257.
Delaney, K.M., R. Guillet, E.K. Pressman, T. Ganz, E. Nemeth, and K.O. O'Brien, Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples. The Journal of Nutrition, 2021. 151(9): p. 2590-2600.
Duong, T.A.D. and T.D. Van, Clinical, Laboratorial Characteristics and Treatment Result of Anemia in Preterm Neonates in Haiphong Children’s Hospital In 2015-2016, Hematology & Hemotherapy Journal. 2018. 3: 005
El Gendy, F.M., M.A. El-Hawy, A.M.F. Shehata, and H.E. Osheba, Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia. European Journal of Haematology, 2018. 100(4): p. 356-360.
Ferri, C., R.S. Procianoy, and R.C. Silveira, Prevalence and risk factors for iron-deficiency anemia in very-low-birth-weight preterm infants at 1 year of corrected age. J Trop Pediatr, 2014. 60(1): p. 53-60.
Jeon, G.W. and J.B. Sin, Risk factors of transfusion in anemia of very low birth weight infants. Yonsei Med J, 2013. 54(2): p. 366-73.
Kautz, L., G. Jung, X. Du, V. Gabayan, J. Chapman, M. Nasoff, et al., Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. Blood, The Journal of the American Society of Hematology, 2015. 126(17): p. 2031-2037.
Kling, P.J., Iron nutrition, erythrocytes, and erythropoietin in the NICU: erythropoietic and neuroprotective effects. Neoreviews, 2020. 21(2): p. e80-e88.
Lenhartová, N., M. Ochiai, T. Sawano, K. Yasuoka, J. Fujiyoshi, H. Inoue, and S. Ohga, Serum erythroferrone levels during the first month of life in premature infants. Journal of Perinatology, 2022. 42(1): p. 97-102.
Martin, J.A., B.E. Hamilton, P. Sutton, S. Ventura, F. Menacker, and S. Kirmeyer, Births: Final data for 2006. National vital statistics reports. vol. 57, no 7. Hyattsville MD Natl. Cent. Health Stat, 2009.
Melville, J.M. and T.J. Moss, The immune consequences of preterm birth. Front Neurosci, 2013. 7: p. 79.
Nicolas, G., L. Viatte, D.-Q. Lou, M. Bennoun, C. Beaumont, A. Kahn, et al., Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nature genetics, 2003. 34(1): p. 97-101.
Raffaeli, G., F. Manzoni, V. Cortesi, G. Cavallaro, F. Mosca, and S. Ghirardello, Iron Homeostasis Disruption and Oxidative Stress in Preterm Newborns. Nutrients, 2020. 12(6).
Redondo-Muñoz, J., E. Ugarte-Berzal, M.J. Terol, P.E. Van den Steen, M.H. del Cerro, M. Roderfeld, et al., Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain. Cancer cell, 2010. 17(2): p. 160-172.
Soliman, A.T., V. De Sanctis, and S. Kalra, Anemia and growth. Indian J Endocrinol Metab, 2014. 18(Suppl 1): p. S1-5.
Teramo, K.A., M.M. Klemetti, and J.A. Widness, Robust increases in erythropoietin production by the hypoxic fetus is a response to protect the brain and other vital organs. Pediatric research, 2018. 84(6): p. 807-812.
Tsai, A.G., A. Hofmann, P. Cabrales, and M. Intaglietta, Perfusion vs. oxygen delivery in transfusion with "fresh" and "old" red blood cells: the experimental evidence. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2010. 43(1): p. 69-78.
Wang, Y., Y. Wu, T. Li, X. Wang, and C. Zhu, Iron Metabolism and Brain Development in Premature Infants. Front Physiol, 2019. 10: p. 463.
Wardrop, C.A., B.M. Holland, K.E. Veale, J.G. Jones, and O.P. Gray, Nonphysiological anaemia of prematurity. Arch Dis Child, 1978. 53(11): p. 855-60.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
